Document Type

Report

Publication Date

6-4-2024

Comments

This article is the author's final published version in [journal], Volume 3, Issue 2, June 2024, Pages 699 - 701.

The published version is available at https://doi/org/10.1002/jvc2.348. Copyright © 2023 The Authors.

Publication made possible in part by support through a transformative agreement between Thomas Jefferson University and the publisher.

Abstract

We report a case of hairy tongue that developed in a young Caucasian
/="/">woman during systemic baricitinib therapy for severe alopecia areata.
/="/">Because she experienced good clinical regrowth of her hair during
/="/">treatment, she did not want to interrupt therapy. We recommended she
/="/">use a toothbrush to debride her tongue on a daily basis, which was
/="/">successful. Hairy tongue most commonly occurs in elderly, debilitated
/="/">males with poor oral hygiene. It is thought to occur because of overgrowth
/="/">of chromogenic bacteria and/or yeast on the tongue. This unusual side
/="/">effect during baricitinib therapy suggests that immune suppression may
/="/">play a role. Clinicians should be aware of hairy tongue development
/="/">during baracitinib therapy.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Language

English

Download

Share

COinS